Figure 3.

LPS-induced inflammation increases P2ry6 expression in immune cell populations and induces characteristic lung inflammatory changes. Wild-type mice received i.t. administration of PBS or LPS and were euthanized 24 hours later. Cells from BAL and lung tissue were isolated and sorted by flow cytometry, and P2ry6 mRNA expression was assessed by qRT-PCR in (A) CD45+ hematopoietic cells, (B) CD11c-expressing cells, (C) Ly6G+ neutrophils, (D) F4/80+ macrophages, (E) CD4+ T cells, and (F) EpCAM+ epithelial cells. P2ry6 mRNA expression was based on 2-ΔΔCt values normalized to Gapdh. LPS challenge significantly increased P2ry6 expression in immune cell populations but not in EpCAM+ epithelial cells. Data are presented as mean ± SEM; with the number of animals indicated in each graph. Statistical analysis was performed using Welch’s t-test; P < 0.05. (G–I) Representative H&E-stained lung sections showing inflammatory changes following LPS challenge. (G) Focal thickening of alveolar walls with intramural neutrophil accumulation (red arrows) and activated alveolar epithelial cells (black arrow). (H) Neutrophil accumulation within alveolar spaces and alveolar walls (red arrows). (I) Neutrophil accumulation in the alveolar space (black arrow), proteinaceous debris deposition (red arrows) and focal hyaline membrane formation (grey arrow). (J–L) Representative SFOG-stained lung sections demonstrating vascular alterations following LPS challenge. (J) Vascular congestion in small vessels and pulmonary capillaries (white asterisk and green arrows), focal intravascular coagulation (red arrow), and erythrocyte extravasation into the alveolar space (black arrow). (K) Hemorrhage in the peribronchiolar and perivascular regions (black arrows) and bronchial lumen (red arrow). (L) Congestion of small interstitial blood vessels (white arrow) and early thrombus formation (red arrows). Scale bar, 100 µm.